Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Efficacy of hematopoietic stem cell mobilization regimens in patients with hematological malignancies: a systematic review and network meta-analysis of randomized controlled trials

Fig. 3

Forest plot of meta-analysis results for the total number of collected CD34+ cells. Forest plot regarding the network meta-analysis results of the total number of collected CD34+ cells (× 106/kg) for patients with MM (A) and NHL (B). G-CSF SD is the common comparator. Estimate of relative treatment effect for other mobilization regimens are reported as mean differences (MD) with the associated 95% credibility interval (95% CrI). CY, cyclophosphamide; G-CSF, granulocyte colony-stimulating factor; ID-AraC, intermediate-dose cytarabine; RD, reduced dose; SUCRA, surface under the cumulative ranking curve; SD, standard dose; YF-H-2015005, a new CXCR4 antagonist

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512